NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 2 analysts with an average price target of $-46.67. This is a potential upside of $-59.27 (-470.4%) from yesterday's end of day stock price of $12.6.

NextCure 's activity chart (see below) currently has 32 price targets and 36 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.51% with an average time for these price targets to be met of 379.13 days.

Highest price target for NXTC is $15, Lowest price target is $3, average price target is $9.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 14-Jul-2025. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$15

$5.8 (63.04%)

$13

3 months 18 days ago
(14-Jul-2025)

10/11 (90.91%)

$10.24 (215.13%)

507

Buy

$3

$-6.2 (-67.39%)

$3

4 months 1 days ago
(30-Jun-2025)

4/7 (57.14%)

$-2.23 (-42.64%)

336

Buy

$4

$-5.2 (-56.52%)

$4

1 years 3 months ago
(01-Aug-2024)

7/7 (100%)

$-15.2 (-79.17%)

522

Hold

$16

2 years 11 months 29 days ago
(03-Nov-2022)

1/1 (100%)

$-43.04 (-72.90%)

273

Buy

$15

$5.8 (63.04%)

3 years 2 months 10 days ago
(22-Aug-2022)

2/2 (100%)

$-38.28 (-71.85%)

302

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 379.13 days on average for the stock forecasts to be realized with a an average price target met ratio 93.51

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on NXTC (NextCure ) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on NXTC (NextCure )?

Edward Tenthoff works at PIPER SANDLER and has 69 price targets and 54 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Asthika Goonewardene with highest potential upside - $5.8

Which analyst is the currently most reserved on NXTC (NextCure )?

Emily Bodnar with lowest potential downside - -$6.2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?